가와사키병 치료를 위한 아스피린 사용 후 발생한 라이 증후군 1예
A Case of Reye Syndrome Following Treatment of Kawasaki Disease with Aspirin
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
라이 증후군은 간부전을 동반하며 급속히 진행하는 뇌증으로, 인플루엔자와 수두 바이러스 등에 감염된 어린이에게 발병한다. 아스피린이 주된 원인 인자로 알려진 이후 소아에서 아스피린의 사용을 줄이면서 현재는 매우 드물게 보고 되고 있다. 저자들은 가와사키병 치료를 위해 정맥내 면역글로불린을 투여받고 아스피린을 복용하던 중 보챔, 강직, 활동량 저하, 식욕 저하, 처짐, 구토, 간수치 상승, 혈액 응고 장애와 고암모니아혈증으로 치료받은 5개월 여아를 보고하는 바이다.
Abstract
Reye syndrome is a rapidly progressive encephalopathy with hepatic dysfunction, which often begins several days after apparent recovery from a viral illness, especially varicella or influenza A or B. Salicylate use was identified as a major precipitating factor for the development of Reye syndrome. With the recommendation to avoid use of salicylates in children, Reye syndrome has virtually disappeared in recent years. We report a case of Reye syndrome in a 5-month-old infant who had been treated with intravenous immunoglobulin and aspirin under the diagnosis of Kawasaki disease, and showed symptoms of sudden onset of irritability, rigidity, decreased activity, vomiting, poor appetite, lethargy, liver dysfunction without jaundice, coagulopathy, and hyperammonemia.
참고문헌 (16)
- De Vivo DC, "Reye syndrome", Neurol Clin, 3, pp.95~115 (1985)
- Hardie RM, "The changing clinical pattern of Reye's syndrome 1982-1990", Arch Dis Child, 74, pp.400~405 (1996)
- Waldman RJ, "Aspirin as a Risk Factor in Reye's Syndrome", JAMA, 247, pp.3089~3094 (1982)
- Kim KH, "Clinical Observation on Reye syndrome According to the Onset of Age in Children", J Korean Pediatr Soc, 35, pp.788~794 (1992)
- Chow EK, "A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections", J Exp Med, 203, pp.2589~2602 (2006)
- Belay ED, "Reye's syndrome in the United States from 1981 through 1997", N Engl J Med, 340, pp.1377~1382 (1999)
- 방준석, "신생아기 장염에 의하여 발병된 Reye 증후군", Korean Journal of Pediatrics, 49(3), pp.273~277 (2006), 대한소아과학회
- Strauss E, "Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy", Hepatogastroenterology, 39, pp.542~545 (1992)
- Jiang Q, "Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta- analysis", Eur J Gastroenterol Hepatol, 20, pp.1064~1070 (2008)
- O'Brien M, "Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease", Pediatrics, 105, pp.64~ (2000)
- Takahashi M, "Kawasaki syndrome, Reye syndrome, and aspirin", Pediatrics, 77, pp.616~617 (1986)
- Lee JH, "Kawasaki disease with Reye syndrome: report of one case", Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 33, pp.67~71 (1992)
- Park JH, "A case of Reye-like syndrome combined with Kawasaki disease", J Korean Child Neurol Soc, 8, pp.333~336 (2000)
- Orlowski JP, "Whatever happened to Reye's syndrome? Did it ever really exist?", Crit Care Med, 27, pp.1582~1857 (1999)
- Kim JG, "Statistical analysis for the mortality of in-patient in pediatric ward", J Korean Pediatr Soc, 20, pp.933~942 (1977)
- Lovejoy FH Jr, "Clinical staging in Reye syndrome", Am J Dis Child, 128, pp.36~41 (1974)